William R. Thomas's Insider Trades & SAST Disclosures
William R. Thomas's most recent trade in Capital Southwest Corp. was a trade of 2,090 Common Stock done . Disclosure was reported to the exchange on Aug. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William R. Thomas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital Southwest Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 2,090 | 16,151 (0%) | 0% | 0 | Common Stock | |
| Capital Southwest Corp. | William R. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 25.87 per share. | 03 Jun 2024 | 9,400 | 14,061 (0%) | 0% | 25.9 | 243,139 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 8,217 | 4,661 (0%) | 0% | 0 | Common Stock | |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 9,550 | 75,760 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,250 | 13,600 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Kinnate Biopharma Inc | Richard Thomas Williams | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 01 Mar 2024 | 558 | 67,588 | - | 2.6 | 1,445 | Common Stock |
| Kinnate Biopharma Inc | Thomas Williams Richard | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.25 per share. | 01 Dec 2023 | 541 | 68,146 | - | 2.2 | 1,217 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 2,240 | 12,878 (0%) | 0% | 0 | Common Stock | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.30 per share. | 01 Jun 2023 | 541 | 69,228 | - | 4.3 | 2,326 | Common Stock |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 12,000 | 66,210 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,250 | 12,350 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.21 per share. | 01 Mar 2023 | 638 | 67,295 | - | 5.2 | 3,324 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 215,000 | 215,000 | - | - | Employee Stock Option (right to buy) | |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.75 per share. | 01 Dec 2022 | 541 | 67,933 | - | 7.8 | 4,193 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 25,000 | 68,474 | - | 0 | Common Stock | |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 69,969 | 0 | - | - | Stock Appreciation Rights | |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 96.29 per share. | 18 Aug 2022 | 69,969 | 782,666 (0%) | 0% | 96.3 | 6,737,315 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Sale or transfer of securities back to the company at price $ 116.70 per share. | 18 Aug 2022 | 57,732 | 724,934 (0%) | 0% | 116.7 | 6,737,324 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.70 per share. | 18 Aug 2022 | 4,816 | 720,118 (0%) | 0% | 116.7 | 562,027 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 2,421 | 10,638 (0%) | 0% | 0 | Common Stock | |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2022 | 45,815 | 0 | - | - | Stock Appreciation Rights | |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.00 per share. | 07 Jun 2022 | 45,815 | 755,492 (0%) | 0% | 127 | 5,818,505 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Sale or transfer of securities back to the company at price $ 142.49 per share. | 07 Jun 2022 | 40,835 | 714,657 (0%) | 0% | 142.5 | 5,818,579 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.49 per share. | 07 Jun 2022 | 1,960 | 712,697 (0%) | 0% | 142.5 | 279,280 | Common Stock |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 8,473 | 54,210 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,250 | 11,100 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| EOG Resources, Inc. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 1,610 | 709,677 (0%) | 0% | 0 | Common Stock | |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.09 per share. | 30 Mar 2022 | 11,266 | 708,067 (0%) | 0% | 121.1 | 1,364,200 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.09 per share. | 30 Mar 2022 | 11,266 | 719,333 (0%) | 0% | 121.1 | 1,364,200 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 121.09 per share. | 30 Mar 2022 | 7,359 | 730,599 (0%) | 0% | 121.1 | 891,101 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 64,133 | 0 | - | - | Stock Appreciation Rights | |
| EOG Resources, Inc. | William R. Thomas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.43 per share. | 16 Mar 2022 | 64,133 | 786,313 (0%) | 0% | 69.4 | 4,452,754 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Sale or transfer of securities back to the company at price $ 112.24 per share. | 16 Mar 2022 | 39,672 | 746,641 (0%) | 0% | 112.2 | 4,452,785 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.24 per share. | 16 Mar 2022 | 8,683 | 737,958 (0%) | 0% | 112.2 | 974,580 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 8.37 per share. | 11 Mar 2022 | 25,000 | 42,333 | - | 8.4 | 209,250 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 8.64 per share. | 11 Mar 2022 | 15,000 | 17,333 | - | 8.6 | 129,600 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 135,000 | 135,000 | - | - | Employee Stock Option (right to buy) | |
| EOG Resources, Inc. | William R. Thomas | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.57 per share. | 29 Sep 2021 | 24,760 | 703,479 (0%) | 0% | 82.6 | 2,044,433 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.81 per share. | 27 Sep 2021 | 6,661 | 728,239 (0%) | 0% | 81.8 | 544,936 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Sale of securities on an exchange or to another person at price $ 27.70 per share. | 09 Sep 2021 | 4,000 | 0 (0%) | 0% | 27.7 | 110,782 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 27.72 per share. | 09 Sep 2021 | 2,000 | 6,000 (0%) | 0% | 27.7 | 55,437 | Common Stock |
| Capital Southwest Corp. | William R. Thomas | Director | Purchase of securities on an exchange or from another person at price $ 27.72 per share. | 09 Sep 2021 | 2,000 | 6,000 (0%) | 0% | 27.7 | 55,442 | Common Stock |
| EOG Resources, Inc. | William R. Thomas | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 42.38 per share. | 30 Jun 2021 | 250 | 734,900 (0%) | 0% | 42.4 | 10,595 | Common Stock |
| NOV Inc | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 9,819 | 45,737 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | William R. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,250 | 9,850 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| EOG Resources, Inc. | William R. Thomas | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.56 per share. | 28 Feb 2021 | 11,718 | 734,650 (0%) | 0% | 64.6 | 756,514 | Common Stock |
| Kinnate Biopharma Inc | Richard Thomas Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| EOG Resources, Inc. | William R. Thomas | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 35,698 | 746,368 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | William R. Thomas | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 1,100 | 8,600 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges